All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Endocytosis Inhibition | NCIT_C40805 | [Endocytosis Inhibition involves interference with, or restraint of, cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles by invagination of the plasma membrane.] |
| Phagocytosis Inhibition | NCIT_C40806 | [Phagocytosis Inhibition involves interference with, or restraint of, the process of endocytosis of particulate material by phagocytes, such as microorganisms or cellular fragments and debris, into membranous phagosomes that fuse with lysosmes and result in digestion of the ingested material; an important defense against infection. (NCI)] |
| Hour Times Femtogram Per Milliliter Per Kilogram | NCIT_C112299 | [Hours times femtograms per milliliter, divided by kilograms.] |
| Histone 2B Antibody Measurement | NCIT_C112295 | [The determination of the amount of histone 2b antibody present in a sample.] |
| Histone Antibody Measurement | NCIT_C111209 | [A measurement of histone antibodies present in a sample.] |
| Histone 3 Antibody Measurement | NCIT_C112296 | [The determination of the amount of histone 3 antibody present in a sample.] |
| Histone 4 Antibody Measurement | NCIT_C112297 | [The determination of the amount of histone 4 antibody present in a sample.] |
| Hour Times Femtogram Per Milliliter Per Gram | NCIT_C112298 | [Hours times femtograms per milliliter, divided by grams.] |
| HER2 Antigen Measurement | NCIT_C112291 | [The determination of the amount of HER2 antigen, including peptides, epitopes, and receptor, present in a sample.] |
| Herpes Simplex Virus 6 Antibody Measurement | NCIT_C112292 | [The determination of the amount of herpes simplex virus 6 antibody present in a sample.] |
| Histone 1 Antibody Measurement | NCIT_C112293 | [The determination of the amount of histone 1 antibody present in a sample.] |
| Histone 2A Antibody Measurement | NCIT_C112294 | [The determination of the amount of histone 2a antibody present in a sample.] |
| Paramyxovirinae | NCIT_C14307 | [The subfamily of Paramyxoviridae which includes Mumps and Measles viruses.] |
| Exocytosis Induction | NCIT_C40808 | [Exocytosis Induction involves initiation of the cellular release of secretory products within membrane-limited vesicles or granules.] |
| Exocytosis Inhibition | NCIT_C40809 | [Exocytosis Inhibition involves interference with, or restraint of, the cellular release of secretory products granules.] |
| Vaccine Related Development, Non-Cancer; Non-AIDS | NCIT_C15870 | |
| Vaccine Related Non-Development, AIDS | NCIT_C15871 | |
| Vaccine Related Non-Development, Non-AIDS | NCIT_C15872 | |
| Phase III Large Scale Vaccine Trial | NCIT_C15873 | [Select suitable vaccine candidates and support efficacy trials when appropriate criteria are met.] |
| Validation of Clinical Utility of Markers | NCIT_C15874 |